Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (COBALT)

This study has been terminated.
(recommendation from the IDMC (Independent Data Monitoring Committee))
Information provided by (Responsible Party):
Opko Health, Inc. Identifier:
First received: July 10, 2007
Last updated: November 5, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2009
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)